TCM
PHAS

Towercrest Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Towercrest Capital Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,051,940
Closed -$1.39M – 94
2022
Q1 		$1.39M Buy
+1,051,940
New +$1.39M 0.27% 45